Publications, Guidelines & Journals
COVID-19 related recommendations
EUSOBI recommendations for breast imaging and cancer diagnosis during and after the COVID-19 pandemic
In this document the European Society of Breast Imaging (EUSOBI) provides recommendations for breast care provision and procedural prioritization at the times of the COVID-19 pandemic, being aware that medical decisions must be taken balancing individual and community safety as well as the safety of healthcare workers.
ESR eBook for Undergraduate Education in Radiology – Breast Imaging Chapter
The eBook for Undergraduate Education in Radiology is a project developed by the Education Committee and the Undergraduate Education Subcommittee of the European Society of Radiology. This eBook has been created to serve medical students, but also residents in their first year(s) of training, as well as academic teachers throughout Europe to understand and teach radiology as a whole coherent discipline, respectively.
We are happy to inform you that EUSOBI contributed to this eBook with the 14th chapter dedicated to Breast Imaging.
Authors: Filipe Barros Alves, Pascal A.T. Baltzer, Melis Baykara Ulusan, Paola Clauser, Francesca Ferrara, Francesca Galati, Elisabetta Giannotti, Fiona J. Gilbert, Fleur Kilburn-Toppin, Maria Adele Marino, Jessica Muscat, Federica Pediconi, Simone Schiaffino, Rubina Manuela Trimboli, Chantal Van Ongeval, Thiemo J.A. van Nijnatten, Giulia Vatteroni, Mirjam Wielema
Screening & Beyond
We are happy to introduce the book, ‘Screening & Beyond’, created especially for the International Day of Radiology 2016.
It is packed with information provided by many of the world’s top experts on breast imaging, including member of EUSOBI – European Society of Breast Imaging, the Society of Breast Imaging, ESTRO, European Institute for Biomedical Imaging Research and EUROPA DONNA – The European Breast Cancer Coalition
European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision.
Schiaffino S, Pinker K, Cozzi A, Magni V, Athanasiou A, Baltzer PAT, Camps Herrero J, Clauser P, Fallenberg EM, Forrai G, Fuchsjäger MH, Gilbert FJ, Helbich T, Kilburn-Toppin F, Kuhl CK, Lesaru M, Mann RM, Panizza P, Pediconi F, Sardanelli F, Sella T, Thomassin-Naggara I, Zackrisson S, Pijnappel RM.
Insights Imaging. 2023 Jul 19;14(1):126. doi: 10.1186/s13244-023-01453-2. PMID: 37466753; PMCID: PMC10356714.
Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
Ritse M. Mann, Alexandra Athanasiou, Pascal A. T. Baltzer, Julia Camps-Herrero, Paola Clauser, Eva M. Fallenberg, Gabor Forrai, Michael H. Fuchsjäger, Thomas H. Helbich, Fleur Killburn-Toppin, Mihai Lesaru, Pietro Panizza, Federica Pediconi, Ruud M. Pijnappel, Katja Pinker, Francesco Sardanelli, Tamar Sella, Isabelle Thomassin-Naggara, Sophia Zackrisson, Fiona J. Gilbert & Christiane K. Kuhl On behalf of the European Society of Breast Imaging (EUSOBI)
Eur Radiol (2022). https://doi.org/10.1007/s00330-022-08617-6
Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI)
Simone Schiaffino, Katja Pinker, Veronica Magni, Andrea Cozzi, Alexandra Athanasiou, Pascal A. T. Baltzer, Julia Camps Herrero, Paola Clauser, Eva M. Fallenberg, Gábor Forrai, Michael H. Fuchsjäger, Thomas H. Helbich, Fleur Kilburn-Toppin, Christiane K. Kuhl, Mihai Lesaru, Ritse M. Mann, Pietro Panizza, Federica Pediconi, Ruud M. Pijnappel, Tamar Sella, Isabelle Thomassin-Naggara, Sophia Zackrisson, Fiona J. Gilbert & Francesco Sardanelli
Insights Imaging 12, 119 (2021). https://doi.org/10.1186/s13244-021-01062-x
Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.
Baltzer, P., Mann, R.M., Iima, M., Sigmund E.E., Clauser P., Gilbert F.J., Martincich L., Partridge S.C., Patterson A., Pinker K., Thibault F., Camps-Herrero J. & Le Bihan D., on behalf of the EUSOBI International Breast Diffusion-Weighted Imaging Working Group
Eur Radiol 30, 1436–1450 (2020). https://doi.org/10.1007/s00330-019-06510-3
Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging
Andrew Evans, Rubina M. Trimboli, Alexandra Athanasiou, Corinne Balleyguier, Pascal A. Baltzer, Ulrich Bick, Julia Camps Herrero, Paola Clauser, Catherine Colin, Eleanor Cornford, Eva M. Fallenberg, Michael H. Fuchsjaeger, Fiona J. Gilbert, Thomas H. Helbich, Karen Kinkel, Sylvia H. Heywang-Köbrunner, Christiane K. Kuhl, Ritse M. Mann, Laura Martincich, Pietro Panizza, Federica Pediconi, Ruud M. Pijnappel, Katja Pinker, Sophia Zackrisson, Gabor Forrai, Francesco Sardanelli, for the European Society of Breast Imaging (EUSOBI), with language review by Europa Donna – The European Breast Cancer Coalition
Insights Imaging (2018). https://doi.org/10.1007/s13244-018-0636-z
A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice.
Clauser P, Mann R, Athanasiou A, Prosch H, Pinker K, Dietzel M, Helbich TH, Fuchsjäger M, Camps-Herrero J, Sardanelli F, Forrai G, Baltzer PAT.
Eur Radiol. 2017 Nov 22. doi: 10.1007/s00330-017-5121-4
Mammography: an update of the EUSOBI recommendations on information for women.
Sardanelli F, Fallenberg EM, Clauser P, Trimboli RM, Camps-Herrero J, Helbich TH, Forrai G; European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition.
Insights Imaging. 2017 Feb;8(1):11-18. doi: 10.1007/s13244-016-0531-4. Epub 2016 Nov 16.
Translations: Estonian, Hungarian, Lithuanian, Polish, Portuguese, Serbian, Spanish, Turkish
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
Sardanelli F, Aase HS, Álvarez M, Azavedo E, Baarslag HJ, Balleyguier C, Baltzer PA, Beslagic V, Bick U, Bogdanovic-Stojanovic D, Briediene R, Brkljacic B, Camps Herrero J, Colin C, Cornford E, Danes J, de Geer G, Esen G, Evans A, Fuchsjaeger MH, Gilbert FJ, Graf O, Hargaden G, Helbich TH, Heywang-Köbrunner SH, Ivanov V, Jónsson Á, Kuhl CK, Lisencu EC, Luczynska E, Mann RM, Marques JC, Martincich L, Mortier M, Müller-Schimpfle M, Ormandi K, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Rissanen T, Rotaru N, Saguatti G, Sella T, Slobodníková J, Talk M, Taourel P, Trimboli RM, Vejborg I, Vourtsis A, Forrai G.
Eur Radiol. 2017 Jul;27(7):2737-2743. doi: 10.1007/s00330-016-4612-z. Epub 2016 Nov 2.
Translations: Estonian, Hungarian, Lithuanian, Polish, Portuguese, Serbian, Spanish, Turkish
Breast MRI: EUSOBI recommendations for women’s information.
Mann RM, Balleyguier C, Baltzer PA, Bick U, Colin C, Cornford E, Evans A, Fallenberg E, Forrai G, Fuchsjäger MH, Gilbert FJ, Helbich TH, Heywang-Köbrunner SH, Camps-Herrero J, Kuhl CK, Martincich L, Pediconi F, Panizza P, Pina LJ, Pijnappel RM, Pinker-Domenig K, Skaane P, Sardanelli F; European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition.
Eur Radiol. 2015 Dec;25(12):3669-78. doi: 10.1007/s00330-015-3807-z. Epub 2015 May 23. Review.
Translations: Estonian, Hungarian, Lithuanian, Portuguese, Serbian, Spanish, Turkish
Mammography: EUSOBI recommendations for women’s information.
Sardanelli F, Helbich TH; European Society of Breast Imaging (EUSOBI).
Insights Imaging. 2012 Feb;3(1):7-10. doi: 10.1007/s13244-011-0127-y. Epub 2011 Oct 28.
Breast MRI: guidelines from the European Society of Breast Imaging.
Mann RM, Kuhl CK, Kinkel K, Boetes C.
Eur Radiol. 2008 Jul;18(7):1307-18. doi: 10.1007/s00330-008-0863-7. Epub 2008 Apr 4. No abstract available.
Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures.
Wallis M, Tardivon A, Helbich T, Schreer I; European Society of Breast Imaging.
Eur Radiol. 2007 Feb;17(2):581-8. Review. Erratum in: Eur Radiol. 2007 Feb;17(2):589. Tarvidon, Anne [corrected to Tardivon, Anne].
March 8, 2022: EUSOBI recommends MRI screening in women with extremely dense breasts
Vienna, Austria – March 8, 2022 – The European Society of Breast Imaging released its new recommendations for screening of women with extremely dense breasts today. In this recommendation EUSOBI steps away from the one-size-fits all approach of biennial mammography that is currently adopted by most European screening organizations and advocates for tailored screening programs that take the characteristics and personal wishes of individual women into account.
Women with extremely dense breast tissue have about two times more chance to develop breast cancer than the average woman. Simultaneously, the sensitivity of mammography is reduced because cancers are being masked by overprojecting fibroglandular breast tissue. After careful consideration of the evidence, particularly the results of the Dutch DENSE trial, EUSOBI now recommends that women with extremely dense breast tissue are offered screening with breast MRI. In these women, breast MRI can reduce the mortality from breast cancer and is highly cost-effective.
“We have known for a long time that the performance of mammography screening in women with extremely dense breasts is not very good” says Fiona Gilbert, current president of EUSOBI. “However, we had nothing better to offer. The recent MRI screening trials have largely changed this.”
The new recommendation has far-reaching consequences for all women, as it implies that they should be informed of their breast density when screened. EUSOBI calls on all screening organizations to provide women with this information. The recommendation also acknowledges that there are clear downsides of screening for breast cancer, and calls on breast radiologists to inform women appropriately.
“Women should have a say in if and how they want to be screened. This implies on one hand that we must offer women all methods – including breast MRI – that are proven effective, while on the other hand we should never hold it against them when they opt for less effective methods or even no screening at all” says Ritse Mann, chair of EUSOBI’s scientific committee and first author of the new recommendation.
EUSOBI acknowledges that it may take time before the new recommendations are implemented, and that the level of implementation is dependent on the resources that are available locally. A webinar for further explanation and discussion of the recommendation is planned. EUSOBI is always willing to advice on local implementation of its recommendations.
The full recommendation can be found here: https://doi.org/10.1007/s00330-022-08617-6
EUSOBI is Europe’s prime association of breast imaging specialists. EUSOBI is a daughter society of the European Society of Radiology (ESR). The core members of EUSOBI are dedicated breast radiologists who are best positioned to bring together the clinical and theoretical realities of breast imaging. Other scientists are welcome as associate members. EUSOBI thus brings together extensive expertise on imaging based breast care, ranging from screening applications to image guided treatment and follow-up.
For further information, please contact: firstname.lastname@example.org
October 2018: Record number of participants travel to Athens to attend the EUSOBI Annual Scientific Meeting 2018
October 2018 (ESR, Vienna) – Athens played host to the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting, which took place on 11-13 October and saw its highest level of participation since the society was founded. With over 900 in attendance, the congress is on the fast lane to become the universal leading meeting in breast imaging.
Held in a different location each year, this year’s meeting saw over 100 additional participants compared to last year’s congress in Berlin.
The annual meeting was organised in collaboration with the Hellenic Society of Breast Imaging and involved the active participation of many Greek radiologists, but also pathologists, breast surgeons, medical oncologists and radiation oncologists. These participants, as well as many other worldwide experts helped bring an exciting programme to audiences, with highlights including dedicated sessions on tomosynthesis in screening/diagnostic settings, artificial intelligence and evidence-based imaging, and advanced/multiparametric ultrasound. This year’s EUSOBI Gold Medal, an award introduced in 2014, was given to Professor Christiane K. Kuhl from Aachen/Germany.
Part of the meeting’s success can be attributed to its expanded programme. This year, EUSOBI extended the congress to 2.5 days, offering a variety of pre-congress courses. These courses included updates on case-based BI-RADS classification, interventional procedures and B3 lesions. In addition and for the first time, the EUSOBI Young Club Committee organised a post-congress special symposium dedicated to young radiologists with an interest in breast imaging and diagnostics.
EUSOBI Past-President, Professor Gábor Forrai from Budapest/Hungary, is delighted with the annual meeting’s growth over the course of his three-year presidency. ‘Each year, I am so happy to see more and more people taking an interest in breast imaging. The fact that they are willing to give their time to come teach, learn and share ideas with colleagues here in Athens is an impressive mark of how dedicated those working in this field are’. During the congress in Athens Doctor Julia Camps Herrero from Valencia/Spain took over the presidency for the next two years. She will be taking office at an exciting time for the society, with EUSOBI having just reached a milestone of serving over 1,000 members for the first time since it was founded.
The European Society of Radiology (ESR) would like to congratulate the European Society of Breast Imaging and the Hellenic Society of Breast Imaging for the success of the meeting and look forward to seeing more great things from EUSOBI in the future.
You can learn more about EUSOBI’s annual meeting here.
September 22, 2016: EUSOBI Annual Scientific Meeting to kick off in Paris tomorrow
Thursday, September 22, 2016 (EUSOBI) – The European Society of Breast Imaging (EUSOBI) will hold its Annual Scientific Meeting in Paris, La Villette, in collaboration with the Society of Female Imaging – Société d’Imagerie de la Femme (SIFEM) on September 23–24, 2016. A breast magnetic resonance imaging (MRI) course for radiologists is also being held in advance on September 21–22.
Some 660 registered participants are expected to attend this year’s Annual Meeting, confirming a continuously increasing number of attendees over the years.
EUSOBI offers a balanced programme with cutting-edge science and good everyday practice. The Paris meeting will be a perfect opportunity to meet and exchange knowledge with experts and breast radiologists, as well as related companies from all over Europe and beyond.
The EUSOBI National Societies Network is made up of 29 countries. The first position paper from this large group of breast radiology societies will be published in European Radiology in October 2016, addressing the fundamental role of screening mammography for reducing the breast cancer mortality. EUSOBI unequivocally recommends all women to attend screening, according to their countries’ protocols.
This year, the 30th anniversary of contrast-enhanced breast MRI (1986–2016) will be celebrated with the EUSOBI Gold Medal Lecture delivered by Prof. Sylvia Heywang-Köbrunner, who was the first to report on this excellent diagnostic method in 1986. The Keynote Lecture will be delivered by Prof. Hedvig Hricak (Chairman of the Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, USA) on oncologic imaging in clinical decision making. The President of the U.S. Society of Breast Imaging, Prof. Elizabeth Morris (Chief of Breast Imaging at the Memorial Sloan-Kettering Cancer Center, New York, USA), will present the latest research and achievements in metastatic breast cancer.
The ‘Best way to screen’ session will tackle a hot topic as the debate on breast screening continues while the ‘Cutting edge’ and ‘B3 management’ sessions will include the latest scientific achievements. EUSOBI is currently focusing on breast MRI as this method already plays a major role in daily care, therapy planning and determining disease prognosis.
The EUSOBI Young Club will welcome its new active members at the special young scientists’ session, where the Young Investigator Award will be handed over and the best submitted poster abstracts will be presented.
EUSOBI will announce its new ‘5 points against breast cancer’ in Paris:
- In Europe, there are slightly different breast screening protocols in every country, but one statement is uniform: mammography saves lives and life quality – it can decrease breast cancer death by up to 40%.
- One in five breast cancers occur in women below 50, so screening should start before this age, at least at 45.
- 45% of breast cancers and related deaths occur in women at 65 and over. One in three breast cancers occur in women over 70, so screening should not stop at this age, but continue at least up to 75.
- If a woman has breast symptoms, the breast radiologist is the doctor to meet – he/she integrates all diagnostic techniques in order to give the most accurate information on breast health status e. g. cancer disease.
- The woman’s risk profile matters: personalised screening protocols may include ultrasound and/or MRI – but should always be interpreted together with mammography.
Digital breast tomosynthesis (DBT): a review of the evidence for use as a screening tool
Gilbert FJ, Tucker L, Young KC
Clinical Radiology. 2016 Feb;71(2):141-50. doi: 10.1016/j.crad.2015.11.008
CONCERNS ABOUT SAFETY OF GADOLINIUM-BASED CONTRAST AGENTS (GBCAs)
A controversial debate about the safety of GBCAs recently prompted the European Medicines Agency and the U.S. Food and Drug Administration (see documents: FDA, EMA, ISMRM), to consider the clinical use of GBCAs in MRI. EUSOBI consider that indications for contrast-enhanced breast MRI as defined in our recommendations (Breast MRI: guidelines from the European Society of Breast Imaging and Breast MRI: EUSOBI Recommendations for women’s information) are still valid, and we believe that no breast MRI examination should be cancelled because the advantages (diagnosing breast cancer) clearly outweigh the possible problems contrast material could cause. We will modify our approach in the light of new evidence if appropriate.
ESR European Training Curriculum for Subspecialisation in Radiology
Submit any breast related news and publications:
EUSOBI has an affiliation agreement with the following medical journals:
The flagship journal of the European Society of Radiology (ESR) continuously updates scientific knowledge in clinical radiology by publishing original research articles of general interest and importance as well as state-of-the-art reviews, and short communications written by leading radiologists. Members of the ESR receive free electronic access to the journal, which is Europe’s No.1 journal for general radiology. More information at www.european-radiology.org
European Radiology Experimental
The youngest member of the ESR journal family concentrates on basic scientific discoveries, novel approaches and techniques in experimental settings in the field of medical imaging. It is an online gold open access journal. Article Processing Charges for publication in European Radiology Experimental are covered for all corresponding authors who are active members of the ESR. More information at www.er-x.org
Insights into Imaging
This online gold open access journal specialises on critical reviews, guidelines and policy statements, and is dedicated to education and strategies in radiology. Article Processing Charges for publication in Insights into Imaging are covered for all corresponding authors who are active members of the ESR. More information at www.i3-journal.org